CONTEXT: Although tissue plasminogen activator (tPA) is an effective treatment for stroke patients, it typically must be administered within 3 hours of symptom onset to substantially reduce morbidity and mortality. Because of this limited treatment window, it is essential for healthcare professionals to properly identify and quickly triage stroke patients. OBJECTIVE: To determine if implementation of a stroke alert protocol coupled with a limited education program will reduce arrival time to computed tomography scan time and treatment time for stroke patients in the emergency department (ED). METHODS: This prospective pilot study took place at Geisinger Medical Center in Danville, Pennsylvania, and included a formal stroke protocol based pa...
Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated ...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Background and hypothesis: Thrombolytic therapy with tissue plasminogen activator is effective for a...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hem...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Objective: To assess the effectiveness of the PAST (Pre-hospital Acute Stroke Triage) protocol in re...
Background: Time matters in stroke care, and every second counts because the extent of irreversible ...
BACKGROUND AND AIMS: Thrombolytic therapy with intravenous recombinant tissue plasminogen activator...
Background and Purpose: Several emerging stroke therapies require patients to be treated within seve...
Background: Every forty seconds a stroke occurs and every four minutes someone in the United States ...
INTRODUCTION: Timely emergency department (ED) recognition of acute strokes reduces morbidity and mo...
Background: Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) is licensed f...
Study Objectives: Prompt identification of stroke is essential as primary interventions such as tiss...
Place: United StatesInternational audienceBACKGROUND AND PURPOSE: Following the reorganization of a ...
Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated ...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Background and hypothesis: Thrombolytic therapy with tissue plasminogen activator is effective for a...
BACKGROUND: This study aims to evaluate the effectiveness of implementing a stroke protocol (SP) in ...
Introduction: Stroke is a development of an acute focal neurological deficit with an ischemic or hem...
Objective: Ischemic strokes cause significant morbidity and mortality. Treatment with tissue plasmin...
Objective: To assess the effectiveness of the PAST (Pre-hospital Acute Stroke Triage) protocol in re...
Background: Time matters in stroke care, and every second counts because the extent of irreversible ...
BACKGROUND AND AIMS: Thrombolytic therapy with intravenous recombinant tissue plasminogen activator...
Background and Purpose: Several emerging stroke therapies require patients to be treated within seve...
Background: Every forty seconds a stroke occurs and every four minutes someone in the United States ...
INTRODUCTION: Timely emergency department (ED) recognition of acute strokes reduces morbidity and mo...
Background: Thrombolytic therapy with recombinant tissue plasminogen activator (rt-PA) is licensed f...
Study Objectives: Prompt identification of stroke is essential as primary interventions such as tiss...
Place: United StatesInternational audienceBACKGROUND AND PURPOSE: Following the reorganization of a ...
Introduction: Delays in door to skin puncture time for patients with ischemic stroke are associated ...
Explaining the risks and benefits of recombinant tissue-plasminogen activator (rtPA) to eligible pat...
Background and hypothesis: Thrombolytic therapy with tissue plasminogen activator is effective for a...